As patients and employers look for alternatives to pricey GLP-1 drugs, Silicon Valley startup Twin Health is using AI and wearable sensors to help people make healthier choices. Rodney Buckley has lost 100 pounds in less than a year, not by using a GLP-1 drug but with the help of a digital twin. Last March, the 55-year-old retired firefighter turned village mayor of Third Lake, Illinois, was 376 pounds. He had tried different diets over the years and would typically lose some weight but eventually gain it back. When his wife's employer started offering a program from startup Twin Health, he thought he would give it a try.

In this paper, we address this gap by dividing a typical patient's clinical journey

The "Patient Instruction" (PI), which contains critical instructional information provided bothtocarers andtothepatient atthetimeofdischarge,isessential for the patient to manage their condition outside hospital.

Over half of cancer patients experience long-term pain management challenges.

Signos is the first FDA-cleared, AI-enabled system that uses CGMs to nudge you towards healthier behaviors. According to the American Diabetes Association, around 7 million people in the United States are undiagnosed, with 1 in 3 Americans at risk for developing type 2 diabetes. If you do not go on medication, you can manage the condition--a chronic metabolic disease that's characterized by elevated blood sugar levels--by exercising and watching what you eat (very, very closely). In the past few years, the tools that diabetics use to help manage their condition have become more widely available. Continuous glucose monitors (CGMs) like the Abbott Lingo and the Dexcom Stelo used to be available only by prescription.

Scientists are trying to understand why. New book explores the philosophy of addiction. Our understanding of addiction is changing. Breakthroughs, discoveries, and DIY tips sent every weekday. Reprinted by permission of Princeton University Press.